1,006
Participants
Start Date
October 1, 2015
Primary Completion Date
October 31, 2016
Study Completion Date
December 31, 2016
experimental
corresponding to surviving individuals of a hospitalization in intensive care in a department having set up the program of reduction of the discomforts collected by the patients of intensive care during a minimal period of 5 months. The program is so defined as factor of exposure and supposed protector of development of anxio-depressive disorders.These patients will have been included in the study IPREA3 in 17 centers of the interventional group of the study IPREA3 during the months of April, 2015 and October, 2015
control
"The patients not exposed in the supposed factor protector of development of anxio-depressive disorders will be constituted by the patients estimated in the study IPREA3 corresponding to surviving individuals of a hospitalization in intensive care in a department having never operated the program of reduction of the discomforts collected by the patients of intensive care. These patients will have been included in the study IPREA3 in 17 centers of the group control some study IPREA3 during October 2014 and April, 2015"
CH Troyes, Troyes
CH La Rochelle, La Rochelle
C.H. de Chartres, Chartres
CH Le Puy en Velay, Le Puy-en-Velay
CH Douai, Douai
CH Lens, Lens
CHU NHC, Strasbourg
CHU Hautepierre, Strasbourg
CHU Edouard Herriot, Lyon
CHU Saint Louis APHP, Paris
CHU Cochin APHP, Paris
CHU Beaujon APHP, Clichy
Centre Hospitalier of Chartres
OTHER